Cyclical sequential hormonochemotherapy in advanced breast cancer.
作者信息
Ghilchik M W, Shaikh N A, Beranek P A, Reed M J
机构信息
Breast Clinic, St Mary's Hospital, London.
出版信息
Br Med J (Clin Res Ed). 1987 Nov 7;295(6607):1172. doi: 10.1136/bmj.295.6607.1172.
Abstract
摘要
相似文献
1
Cyclical sequential hormonochemotherapy in advanced breast cancer.
Br Med J (Clin Res Ed). 1987 Nov 7;295(6607):1172. doi: 10.1136/bmj.295.6607.1172.
2
Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.乙炔雌二醇与甲羟孕酮治疗晚期乳腺癌：一项试点研究。
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):135-6.
3
The effects of sequential treatment with ethynyloestradiol and medroxyprogesterone acetate on oestrogen and progestogen receptors in breast cancer.
J Steroid Biochem. 1989;34(1-6):403-5. doi: 10.1016/0022-4731(89)90116-7.
4
Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Clin Oncol. 1980 Jun;6(2):153-7.
5
[Successful treatment of brain metastases in breast cancer with blood-brain barrier-impervious cytostatics and hormones].
Onkologie. 1983 Apr;6(2):58-61. doi: 10.1159/000215201.
6
[Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Onkologie. 1982 Aug;5 Suppl:8-12.
7
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
Am J Clin Oncol. 1982 Oct;5(5):495-9.
8
Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Arch Intern Med. 1981 Jul;141(8):1055-9.
9
[Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].晚期乳腺癌肺转移的激素治疗联合五药疗法（作者译）
Prax Pneumol. 1976 Aug;30(8):479-8.
10
[Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].[采用两种连续化疗方案治疗晚期乳腺癌]
Medicina (B Aires). 1982;42(6 Pt 1):587-95.
引用本文的文献
1
Third meeting of the British Oncological Association. York, 3-5 July, 1988. Abstracts.英国肿瘤学协会第三次会议。1988年7月3日至5日，约克。摘要
Br J Cancer. 1988 Oct;58(4):518-48.
2
Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy.通过DNA聚合酶α活性分析人类乳腺肿瘤增殖及内分泌治疗的效果。
Br J Cancer. 1990 Aug;62(2):263-6. doi: 10.1038/bjc.1990.273.
本文引用的文献
1
Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?
Breast Cancer Res Treat. 1983;3(2):117-27. doi: 10.1007/BF01803554.
2
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.他莫昔芬、普瑞马林、甲氨蝶呤和5-氟尿嘧啶用于转移性乳腺癌的II期试验。
Breast Cancer Res Treat. 1982;2(1):93-9. doi: 10.1007/BF01805721.
3
Kinetics of mammary tumor cell growth and implications for therapy.乳腺肿瘤细胞生长动力学及其对治疗的意义。
Cancer. 1971 Dec;28(6):1479-99. doi: 10.1002/1097-0142(197112)28:6<1479::aid-cncr2820280622>3.0.co;2-m.
Zotero 插件